{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:14:53Z","timestamp":1789020893132,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"pharmaceutical companies marketing Symptomatic Slow Acting Drugs in Osteoarthritis (SYSADOAs)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.semarthrit.2015.10.009","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T21:46:33Z","timestamp":1446241593000},"page":"S34-S41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"S","title":["Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study"],"prefix":"10.1016","volume":"45","author":[{"given":"Lucio C.","family":"Rovati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Giacovelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.10.009_bib1","series-title":"Meyler\u2019s side effects of analgesics and anti-inflammatory drugs","author":"Aronson","year":"2009"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1063-4584(05)80101-3","article-title":"Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop","volume":"4","author":"Altman","year":"1996","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib3","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1002\/art.38869","article-title":"Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain","volume":"66","author":"Dworkin","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.joca.2015.03.005","article-title":"OARSI Clinical Trials Recommendations: design, conduct, and reporting of clinical trials for knee osteoarthritis","volume":"23","author":"McAlindon","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","article-title":"An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"44","author":"Bruy\u00e8re","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib6","first-page":"65","article-title":"Guidelines for testing slow acting drugs in osteoarthritis","volume":"41","author":"Lequesne","year":"1994","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.22371","article-title":"Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator","volume":"56","author":"Herrero-Beaumont","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1529-0131(199801)41:1<81::AID-ART11>3.0.CO;2-9","volume":"41","author":"Maheu","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2515\/therapie:2006063","article-title":"Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France","volume":"61","author":"Lagnaoui","year":"2006","journal-title":"Therapie"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/art.24255","article-title":"Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Kahan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib12","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study","volume":"162","author":"Pavelk\u00e1","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.semarthrit.2015.10.009_bib13","first-page":"779","article-title":"The algofunctional indices for hip and knee osteoarthritis","volume":"24","author":"Lequesne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib14","unstructured":"De Wan M, Volpi G, inventors, Rottapharm assignee. Method of preparing mixed glucosamine salts. USA patent 5,847,107; 1998."},{"key":"10.1016\/j.semarthrit.2015.10.009_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/ecp.09.17","article-title":"Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations","volume":"2","author":"Altman","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib18","first-page":"2407","article-title":"Active ingredient consistency of commercially available glucosamine sulfate products","volume":"29","author":"Russell","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib19","first-page":"CD002946","article-title":"Glucosamine therapy for treating osteoarthritis","volume":"2","author":"Towheed","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib20","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.22852","article-title":"The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest","volume":"56","author":"Reginster","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib21","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/acr.22376","article-title":"Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials","volume":"66","author":"Eriksen","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.10.009_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721500270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721500270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T05:22:26Z","timestamp":1537248146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721500270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S004901721500270X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.10.009","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}